[An in-vitro system study of the immunomodulating activity of taktivin in atopic dermatitis]

In vitro effect of tactivin on E-rosette forming capacity of peripheral blood T lymphocytes of atopic dermatitis patients permits more accurate diagnosis of immunodeficiency degree, evaluation of the relations between T-cell immunity affection and immunomodulation results. Individual sensitivity of ERF cells to tactivin in vitro may be utilized for selection of patients in need for immunocorrection and the latter substantiation.